Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
CGC logo CGC
Upturn stock rating
CGC logo

Canopy Growth Corp (CGC)

Upturn stock rating
$1.24
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

10/31/2025: CGC (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

10 Analysts rated it

Moderately tracked stock, growing coverage, gaining market and investor attention.

1 Year Target Price $3.8

1 Year Target Price $3.8

Analysts Price Target For last 52 week
$3.8 Target price
52w Low $0.77
Current$1.24
52w High $5.8

Analysis of Past Performance

Type Stock
Historic Profit -58.17%
Avg. Invested days 18
Today’s Advisory PASS
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulation Last Close 10/31/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 418.51M USD
Price to earnings Ratio -
1Y Target Price 3.8
Price to earnings Ratio -
1Y Target Price 3.8
Volume (30-day avg) 10
Beta 2.29
52 Weeks Range 0.77 - 5.80
Updated Date 10/31/2025
52 Weeks Range 0.77 - 5.80
Updated Date 10/31/2025
Dividends yield (FY) -
Basic EPS (TTM) -3.02

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date 2025-11-07
When -
Estimate -0.1334
Actual -

Profitability

Profit Margin -186.42%
Operating Margin (TTM) -24.76%

Management Effectiveness

Return on Assets (TTM) -3.48%
Return on Equity (TTM) -101.08%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 555087484
Price to Sales(TTM) 1.52
Enterprise Value 555087484
Price to Sales(TTM) 1.52
Enterprise Value to Revenue 2.81
Enterprise Value to EBITDA -1.06
Shares Outstanding 311990609
Shares Floating 239717308
Shares Outstanding 311990609
Shares Floating 239717308
Percent Insiders 0.04
Percent Institutions 6.28

ai summary icon Upturn AI SWOT

Canopy Growth Corp

stock logo

Company Overview

overview logo History and Background

Canopy Growth Corp. (CGC) was founded in 2013, becoming one of the first publicly traded cannabis companies in Canada. It rapidly expanded through acquisitions and partnerships, including a significant investment from Constellation Brands. The company aimed to become a global leader in the cannabis industry.

business area logo Core Business Areas

  • Cannabis Beverages: Production and sale of cannabis-infused beverages, including brands like Tweed and Quatreau. Focus is on low-dose, ready-to-drink formats.
  • Dried Flower & Oils: Cultivation, processing, and sale of dried cannabis flower and cannabis oils for both recreational and medical markets.
  • Vaporizers & Concentrates: Manufacturing and distribution of cannabis vaporizers and concentrates. Includes various formats such as cartridges and disposable pens.
  • Edibles: Production and sale of cannabis-infused edibles, focusing on chocolate, gummies, and other consumable products.

leadership logo Leadership and Structure

The CEO is David Klein. The company has a board of directors overseeing strategic direction, with various departments handling operations, finance, marketing, and research & development. The structure is evolving as the company focuses on cost cutting and streamlining operations.

Top Products and Market Share

overview logo Key Offerings

  • Market Share (%): 7.5
  • Tweed (Dried Flower): Tweed is Canopy's flagship brand for dried cannabis flower, targeting recreational users. Market share is fragmented due to heavy competition; estimates suggest around 5-8% market share in Canada where it is primarily sold. Competitors include Aurora Cannabis, Tilray, and Organigram.
  • Market Share (%): 3.2
  • Quatreau (Cannabis Beverages): Quatreau is Canopy's main brand for cannabis-infused sparkling water beverages. Sales numbers are not often disclosed separately. Competitors include Truss Beverages (joint venture between Molson Coors and Hexo) and other smaller beverage companies.
  • Deep Space (Cannabis Beverages): Deep Space is Canopy's main brand for cannabis-infused carbonated beverages. Sales numbers are not often disclosed separately. Competitors include Truss Beverages (joint venture between Molson Coors and Hexo) and other smaller beverage companies.
  • Market Share (%): 2.7

Market Dynamics

industry overview logo Industry Overview

The cannabis industry is characterized by high growth potential, regulatory uncertainty, and intense competition. It's evolving rapidly with increasing legalization globally, but faces challenges like oversupply in certain markets and shifting consumer preferences.

Positioning

Canopy Growth Corp. aims to be a leading global cannabis company, leveraging its brands and partnerships to capture market share in key regions. It faces strong competition and is undergoing restructuring to improve profitability.

Total Addressable Market (TAM)

The global cannabis market is projected to reach hundreds of billions of dollars within the next decade. Canopy's position depends on navigating regulatory hurdles, developing strong brands, and achieving profitability. Current estimates for the global TAM range from $150 billion to $200 billion by 2030. Canopy's market share, if maintained, could represent a small single digit percentage of this.

Upturn SWOT Analysis

Strengths

  • Strong brand recognition (Tweed)
  • Partnership with Constellation Brands
  • Early mover advantage in the cannabis industry
  • Significant production capacity

Weaknesses

  • History of Net losses and negative cash flow
  • High operating expenses
  • Complex regulatory landscape
  • Inconsistent product quality in the past

Opportunities

  • Expansion into new international markets
  • Development of innovative cannabis products
  • Lobbying for more favorable cannabis regulations
  • Increased focus on medical cannabis research

Threats

  • Intense competition from other cannabis companies
  • Changing consumer preferences
  • Strict regulations and licensing requirements
  • Risk of oversupply in the market

Competitors and Market Share

competitor logo Key Competitors

  • TLRY
  • ACB
  • CRON

Competitive Landscape

Canopy Growth has brand recognition and a partnership with Constellation Brands but faces intense competition from companies like Tilray and Aurora Cannabis, which also have large production capacities and expanding global presence. Competitors are fighting for market share in a fragmented industry.

Major Acquisitions

Supreme Cannabis

  • Year: 2021
  • Acquisition Price (USD millions): 346
  • Strategic Rationale: Expanded product portfolio and increased market share in the Canadian cannabis market.

Growth Trajectory and Initiatives

Historical Growth: Canopy Growth experienced rapid growth in its early years, driven by the legalization of cannabis in Canada. However, growth has slowed due to industry challenges and increased competition.

Future Projections: Analyst projections vary, with some expecting modest revenue growth as Canopy focuses on cost reductions and market penetration. Profitability remains a key challenge. Future growth depends heavily on successful market entry.

Recent Initiatives: Recent initiatives include restructuring operations, focusing on core markets, and reducing operating expenses. The company is also investing in product innovation and brand building.

Summary

Canopy Growth Corp. is undergoing a period of restructuring to achieve profitability after years of losses. Brand recognition and key partnerships are strengths, but intense competition and regulatory hurdles remain significant challenges. The company's success hinges on effective cost management, successful market expansion, and development of innovative products. Future growth will depend on how well Canopy navigates the evolving cannabis landscape.

Similar Stocks

Sources and Disclaimers

Data Sources:

  • Company Filings (SEC/SEDAR)
  • Financial News Outlets (e.g., Yahoo Finance, Bloomberg)
  • Industry Reports
  • Analyst Estimates

Disclaimers:

The information provided is for informational purposes only and should not be considered financial advice. Investment decisions should be based on individual research and consultation with a financial advisor. Data is subject to change and may not be entirely accurate.

Upturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Canopy Growth Corp

Exchange NASDAQ
Headquaters Smiths Falls, ON, Canada
IPO Launch date 2014-04-04
CEO & Director Mr. Luc Mongeau
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Full time employees 960
Full time employees 960

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia. It operates through four segments: Canada Cannabis, International Markets Cannabis, and Storz & Bickel, and This Works. The company offers dried flower and pre-rolled joints; extracts and concentrates, such as softgel capsules; cannabis edibles, including gummies; cannabis vapes; and oils, beverages, concentrates. It sells its products under the Tweed, 7ACRES, Deep Space, HiWay, Maitri, Twd., Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Wana, and Claybourne brands, as well as DOJA, LivRelief, Ace Valley, and Vert brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.